Gilead's coronavirus treatment remdesivir to cost $3,120 per U.S. patient with private insurance

"At the level we have priced remdesivir and with government programs in place, along with additional Gilead assistance as needed, we believe all patients will have access," Gilead CEO Daniel O'Day said in an open letter.

from Health and Science https://ift.tt/2Zjt8a3
https://ift.tt/eA8V8J
https://ift.tt/2zIUzyH